"Kaiser basically went from having the most restrictive policy to the most robust," said Joy Burkhard, executive director of the nonprofit Policy Center for Maternal Mental Health."
"Since brexanolone was first approved for use, more experience and research have added to information about its efficacy and safety," Kaiser said in a statement.
[
add
]
[
|
|
...
]